We propose 1,3-dimethyl-2-imidazolidinone (DMI) as a novel electrolyte additive. It enhances cycling stability (105.5 mAh g-1 after 200 cycles) and rate capability (99.7 mAh g-1 after 450 cycles at 5C)...
Lin et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: